Clinical Trials DEA THC Treatment 
Cannabis Law Report
NOVEMBER 22, 2019
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?
Weedistry
MARCH 7, 2019
But the cancer cells died each time they were exposed to tetrahydrocannabinol ( THC ), the principal psychoactive ingredient of marijuana. Instead of gaining insight into how cells function, Sanchez had stumbled upon the anti-cancer properties of THC.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedicalJane
JUNE 29, 2018
The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. The Next Move Is On The DEA.
Veriheal
APRIL 11, 2022
Drug Enforcement Agency (DEA). According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”. Groff confirmed that it had completed its first batch of medicinal-grade cannabis for research purposes on Feb.
CannaMD
AUGUST 8, 2020
But CBD’s stolen the spotlight, partially because of its good cop/bad cop relationship with another famous cannabinoid: T etrahydrocannabinol or THC. THC is responsible for marijuana’s psychoactive effects. If you feel “high,” THC’s usually to blame. CBD Scheduling Rule Change.
SpeedWeed
MARCH 25, 2021
A long-awaited clinical trial on using cannabis as a treatment for veterans with PTSD has finally been published in the PLOS One journal , but the results are far less promising than researchers and veterans had hoped. million grant from the Multidisciplinary Association of Psychedelic Studies (MAPS).
SpeedWeed
MARCH 18, 2021
Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. One group self-administered cannabis with 12% THC over three weeks.
Expert insights. Personalized for you.
66 
Let's personalize your content